HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 436 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $51,371,335 | +18.4% | 444,043 | +5.3% | 0.04% | +18.9% |
Q2 2023 | $43,373,079 | -8.1% | 421,712 | -2.5% | 0.04% | -11.9% |
Q1 2023 | $47,208,725 | -17.1% | 432,552 | -13.6% | 0.04% | -14.3% |
Q4 2022 | $56,980,343 | +79.9% | 500,706 | -2.2% | 0.05% | +69.0% |
Q3 2022 | $31,682,000 | -6.2% | 511,904 | +20.9% | 0.03% | -9.4% |
Q2 2022 | $33,765,000 | -26.9% | 423,338 | -3.6% | 0.03% | -11.1% |
Q1 2022 | $46,215,000 | -9.2% | 439,269 | -7.0% | 0.04% | +5.9% |
Q4 2021 | $50,925,000 | -4.6% | 472,575 | -3.0% | 0.03% | -15.0% |
Q3 2021 | $53,354,000 | +28.1% | 487,075 | +9.5% | 0.04% | +29.0% |
Q2 2021 | $41,651,000 | +6.8% | 444,798 | +5.0% | 0.03% | +3.3% |
Q1 2021 | $38,984,000 | +12.4% | 423,551 | -10.7% | 0.03% | +11.1% |
Q4 2020 | $34,679,000 | -0.4% | 474,082 | +5.8% | 0.03% | -12.9% |
Q3 2020 | $34,815,000 | +52.6% | 448,187 | +9.2% | 0.03% | +40.9% |
Q2 2020 | $22,810,000 | +82.2% | 410,395 | -2.9% | 0.02% | +46.7% |
Q1 2020 | $12,522,000 | -31.6% | 422,739 | -16.4% | 0.02% | -11.8% |
Q4 2019 | $18,315,000 | +73.6% | 505,935 | +30.6% | 0.02% | +70.0% |
Q3 2019 | $10,552,000 | +69.4% | 387,522 | +49.7% | 0.01% | +42.9% |
Q2 2019 | $6,229,000 | – | 258,888 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |